Jacksonville shooter SSRI’s, Kids multiple meds, Brian Hooker PhD, World Mercury Project, Autism Tdap link, Coffee delivery drones, Dr. Rashid Buttar, Advanced Medicine, Salt blood pressure, Sucralose I told you so, Statin drug Parkinson’s, Aspirin vascular fail, Prostate surgery consequences and MORE!

Aug 27, 2018 7-9PM ET

Monday on The Robert Scott Bell Show:

Hour 1 – SSRI’s Strike Again

Game tournament mass shooter was prescribed anti-psychotic and antidepressant medications David Katz, the mass shooter who reportedly opened fire on a group of gamers at a “Madden NFL 19” tournament in Florida — killing two fellow gamers, then himself — had been treated for mental illness and prescribed both antipsychotic and antidepressant drugs, according to multiple media reports. “[A]s a teenager he was hospitalized twice in psychiatric facilities and was prescribed anti-psychotic and anti-depressant medications,” reports Fox News. This is yet another documented case of a young male on mind-altering psychotropic drugswho later committed mass murder. See more documented cases as PsychDrugShooters.com.

Polypharmacy Isn’t Just An Old People Thing…

1 in 12 kids taking multiple medications at risk for a major drug interaction: Study Not much is known about how teens and children use prescription medications, but a new study published in Pediatrics provides some insight. Researchers from the University of Illinois at Chicago looked at how many prescriptions are being issued to this age group, how many medications they were taking at one time, as well as major drug interactions. The authors collected health information of over 23,000 children 19 years and younger using the National Health and Nutrition Examination Survey from 2003 to 2014. Nearly one in five children and adolescents used at least one prescription medication; approximately 7.5 percent used two or more and the use of prescription medications was the highest among adolescent girls (28 percent) and boys ages 6 to 12 years (26.5 percent).

Special Guest Brian Hooker PhD

Dr. Hooker is the father of a vaccine-injured child, and is a Ph.D. researcher. He has fought against the CDC for more than 14 years, using the Freedom of Information Act to try and gather as much data as he could from the studies that the CDC has published that claim there is no link between vaccines and autism. He has submitted much of the results of his own internal investigation of the CDC data on vaccines and autism to Congress. Congressman Bill Posey has assisted him in forcing the CDC to comply with many of these requests.

Study Claims Tdap Vaccine in Pregnancy Doesn’t Cause Autism—Is That True Given The Facts? Since 2012, Tetanus, diphtheria and pertussis (Tdap) vaccine has been recommended for pregnant women during the third trimester of each pregnancy to provide protection to the newborn despite the glaring lack of safety data. The studyPrenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder (ASD)” by Kaiser Permanente was published this week in the journal Pediatrics, the official journal of the American Academy of Pediatrics (AAP). The study touted that the Tdap vaccine during pregnancy doesn’t cause autism. Mainstream media copied the journal’s press release and wrote stories with vigor not questioning how the study was done, who paid for it nor the results. Brian Hooker and the World Mercury Project team dug deeper to find the real answers for you and your loved ones in order to evaluate the vaccine’s risks and benefits during pregnancy.

Super Don Want’s This For Christmas

A coffee delivery drone could predict when you need a caffeine boost Your cup of Joe could soon be coming to you by drone. IBM has filed a new patent for a device that will deliver coffee by air when it decides you need caffeine. The technology includes a device that can track energy, blood pressure and even your pupil size. If you need an energy boost, the drone will bring you a hot cup of coffee. Right now, it’s just an idea, so there’s no word on when or if the service will be available.

 


Hour 2 – Advanced Medicine with Dr. Rashid Buttar!

Dr. Buttar is back to talk about what’s happening in the world of health news. Here’s what we have in store for you today:

Patients with high blood pressure unlikely to reduce salt: More drugs needed to treat hypertension due to increased salt intake Patients with high blood pressure are relying solely on medication to reduce their risk of heart attack, stroke and heart failure, rather than decreasing salt intake as instructed by their physicians, according to research presented today at ESC Congress 2018, the annual meeting of the European Society of Cardiology. Lack of adherence to recommended lifestyle changes is leading to higher salt intake for hypertensive patients, more medications needed to treat their condition and more side effects from those medications, according to lead author Dr Kazuto Ohno, Enshu Hospital, Hamamatsu, Japan.

Study finds sucralose produces previously unidentified metabolites Sucralose, a widely used artificial sweetener sold under the trade name Splenda, is metabolized in the gut, producing at least two fat-soluble compounds, according to a recent study using rats. The finding differs from the studies used to garner regulatory approval for sucralose, which reported that the substance was not broken down in the body. The new study also found that sucralose itself was found in fatty tissues of the body. The researchers used the same experimental model used by the Food & Drug Administration (FDA) to assess the safety of foods based on accepted daily intake. In this case, that involved administering an average dose of 80.4 milligrams/kilogram/day to 10  for 40 days. Urine and feces from the rats were collected and assessed for those 40 days, and for the following two weeks. At the end of the two-week follow-up period, fatty tissue from a subset of the rats was also tested. The researchers, from North Carolina State University and Avazyme Inc. – an analytical testing company—used techniques designed to detect both fat- and water-soluble metabolites. That’s significant because industry did not use state-of-the-art techniques that targeted the full suite of fat-soluble metabolites in the studies it submitted to the FDA when seeking FDA approval for sucralose.

Risk of Parkinson’s disease increases with statin drug use What if the drug meant to treat you actually gave you a different, just-as-bad disease? A report published in the medical journal Movement Disorders says this could be the case with statins, linking the use of the drugs to an increased risk of Parkinson’s disease. Statins are a class of drugs prescribed to prevent heart attacks and strokes. The drug works by blocking the liver enzyme responsible for the production of cholesterol. By doing this, the drug lowers your body’s cholesterol levels and decreases your risk for cardiovascular conditions. Some medical professionals have come to attribute statins with neuroprotective effects, but the authors of the study say the evidence for this is inconclusive at best. Dr. Xuemei Huang, a professor of neurology at Penn State College of Medicine and one of the authors of the study, implies this could be a misunderstanding. Past research suggests that higher cholesterol levels could reduce the risk for Parkinson’s. Incidentally, statins are prescribed to people who need to lower their cholesterol levels.

Aspirin does not reduce initial vascular events in low-to-moderate risk population In a moderate-risk population with low event rates, aspirin did not significantly reduce initial vascular events, according to the ARRIVE study presented at the European Society of Cardiology Congress. Among 12,546 patients randomly assigned to receive enteric-coated aspirin (Bayer) 100 mg daily or placebo and followed for a median of 60 months, the primary efficacy endpoint of time to first occurrence of CV death, MI, unstable angina, stroke or transient ischemic attack occurred in 4.29% of the aspirin group vs. 4.48% of the placebo group (HR = 0.96; 95% CI, 0.81-1.13), according to results of an intention-to-treat analysis. “ARRIVE attempted to address the issue of aspirin for primary prevention in subjects at moderate risk for cardiovascular disease in a pragmatic, primary-care-based study,” J. Michael Gaziano, MD, MPH, chief of the division of aging at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, said during a press conference. “We ended up with a lower-risk population than we had intended. The results showed that aspirin did not significantly reduce a composite of vascular events in the intention-to-treat population. The effects of aspirin tended to be the same as in other primary prevention studies.”

Hi Dr. Buttar, Robert and Super Don.

I have a question about my father in law. He’s been put on a catheter indefinitely. His bladder is not emptying on its own. He recently had some work done on his enlarged prostate, which was delayed too long, and this is the end result. His bladder has, for lack of a better word, a herniated area and this is part of the problem. Do you have any suggestions of products we could give him to help remedy this? Thanks for any info you can provide. I love listening to the show, keep fighting the good fight, you are helping so many people.

Sara


Have you registered with Dr. Buttar’s Advanced Medicine website yet?

Go to AdvancedMedicine.com and use invitation code 1358 to register!

VideoBenefits of creating your Free Account…

  • Free access and utilization to the AHEAD MAP (Medical Assessment Program)
  • Free access to 55 Part Medical Secrets Audio Series
  • Free access to Facts on Toxicity Video Series
  • Free access to over 350 hours of archived audio
  • Access to dozens of other videos, audios, tools, articles and resources that have already changed the lives of thousands of people from over 85 different countries!



Remember Friends, The Power to Heal is Yours!


More upcoming RSB events:


You can help get the Robert Scott Bell Show carried on your local talk stations! Just call the station and request they carry the show. Ask them to contact GCN by calling 877-996-4327 ext. 123 and asking for “John” who manages the affiliate broadcast relationships. John can get any local AM or FM radio station connected with the global feed so that they can carry the show.

What would you like to hear from The Robert Scott Bell Show in 2017? Call us at 1-866-939-BELL (2355) and let your voice be heard!

Need it faster? Want to know as soon as content is added? Want the daily show notes? Click here to subscribe to The Robert Scott Bell Show content feed! 

Listen live here 7PM-9PM EST: Talk Stream Live

Previous episodes of the Robert Scott Bell Show: SoundCloud or Natural News Archive for the older shows.

You can now support The Robert Scott Bell Show by buying your supplements at the Natural News Store!

Aloe Vera Gel 3-Pack Special Includes FREE Youth-Derm® – thanks Stockton Aloe1, Inc.!PlusCBD_300x60_RSB15

How does 15% off on EVERY CBD PRODUCT SOUND? Right now for just RSB Show listeners. Click Here, or call CV Sciences at 855-758-7223 or 855-PLUS CBD. Use code RSB15 to get 15% off any products!

You can access the Tru-Align Body System at home by going to http://www.kacelia.com and entering RSB10 to get 10% off!

What keeps RSB and TMB strong through the stress of travel and colder winter months? Better Way Health Beta 1.3-D Glucan! Call them at 1-800-746-7640.

What does RSB drink? Visit Robert’s Water to find out more! ECHO 9 hydrogen-enriched water is even better! Call 1-800-337-7017! For a limited time only, Paul is opening pre-orders for the ECHO 9 unit at the same price as the ECHO 7, yet it produces an astounding 35% more molecular hydrogen (H2)! Plus you still get an additional RSB Show discount! Call now!

Family Wellness kit, including remedies for vaccine injury! Call 1-800-543-3245. Available now for only$89.99 (price includes free shipping) for RSB Show listeners: Click here!

What’s the only kind of silver I take? Sovereign Silver. It’s now available in the Natural News StoreHave you tried the First Aid Gel yet? No more Neosporin.